Benefits, harms and costs of screening mammography in women 70 years and over: A systematic review

Medical Journal of Australia

Volumn 176, Issue 6, 2002, Pages 266-271

  Barratt, Alexandra L ^a   Irwig, Les M ^a   Glasziou, Paul P ^a   Salkeld, Glenn P ^a   Houssami, Nehmat ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AUSTRALIA; BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; CANCER RISK; CANCER SCREENING; CONSULTATION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; ELDERLY CARE; FEMALE; HEALTH CARE UTILIZATION; HUMAN; LIFE EXPECTANCY; MAMMOGRAPHY; MASTECTOMY; POPULATION RESEARCH; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; STATISTICAL MODEL; VALIDATION PROCESS;

EID: 0037128436     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2002.tb04405.x     Document Type: Review

References (24)

1. Efficacy of screening mammography. A meta-analysis
2. Efficacy of breast cancer screening by age
3. Effect of breast cancer screening after age 65
4. Users' guides to the medical literature. XVII. How to use guidelines and recommendations about screening
5. Users' guides to the medical literature. VII. How to use a clinical decision analysis. A. Are the results of the study valid?
6. Assessing the generalizability of prognostic information
7. In search of the best upper age limit for breast cancer screening
8. In search of the best upper age limit for breast cancer screening
9. When should we stop screening?
10. Continuing screening mammography in women aged 70 to 79 years. Impact on life expectancy and cost-effectiveness
11. Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package
12. Breast cancer screening for elderly women with and without comorbid conditions
13. Screening for breast cancer
14. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age
15. The effect of comorbidity on 3-year survival of women with primary breast cancer
16. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program
17. Patterns of breast cancer care in the elderly
18. Breast carcinoma in the elderly patient: An assessment of operative risk, morbidity and mortality
19. Breast disease in elderly women
20. Age-related differences in the quality of life of breast carcinoma patients after treatment